Guideline for Selecting and Managing Midline Catheters vs. PICCs

1. Duration‑Based Device Selection for Peripheral‑Compatible Infusates

• ≤ 5 days: Standard peripheral IV catheters or ultrasound‑guided peripheral IVs are preferred; midlines and PICCs are generally inappropriate unless venous access is difficult. 1
• 6–14 days: Midline catheters are the preferred device for peripheral‑compatible therapies; ultrasound‑guided peripheral IVs are acceptable alternatives, while PICCs are appropriate but not preferred because midlines have fewer complications in this timeframe. 2, 1
• 15–30 days: PICCs become the preferred device because midline failure rates rise after 14 days; midlines remain acceptable up to 4 weeks but carry increased complication risk. 1
• ≥ 31 days: Tunneled catheters or implanted ports are indicated for therapy exceeding 3 months; PICCs remain appropriate for medium‑term therapy (up to 3 months). 3, 4

2. Infusate‑Based Device Selection

• Peripheral‑compatible solutions (pH 5–9, osmolarity < 850 mOsm/L): Midline catheters are appropriate. 5
• Non‑peripheral‑compatible infusates (vesicants, irritants, chemotherapy, high‑osmolarity PN > 850 mOsm/L): PICCs are mandatory; midlines are inappropriate at any duration. 5, 1
• Tip positioning for high‑osmolarity solutions: Catheter tip must reside in the lower third of the superior vena cava or upper right atrium. 5, 6
• Alternative for ≤ 14 days: Non‑tunneled central venous catheters are acceptable if skilled operators are available. 1

3. Special Clinical Situations

3.1 Difficult Venous Access

• 6–14 days: Ultrasound‑guided peripheral IVs or midlines are preferred over PICCs. 1
• ≥ 15 days: PICCs are appropriate. 1
• Deep arm veins: Ultrasound guidance enables midline placement in basilic or brachial veins when superficial veins are absent. 2

3.2 Frequent Blood Sampling (≥ 3 phlebotomies/day)

• ≤ 5 days: Decision should involve shared discussion of risks/benefits; evidence is uncertain. 1
• ≥ 6 days: PICCs are appropriate. 1
• All durations: Implanted ports are inappropriate for frequent draws. 1

3.3 Parenteral Nutrition (PN)

• Peripheral PN via midline: Requires osmolarity ≤ 850 mOsm/L and limited duration. 5, 2
• High‑osmolarity PN: Requires central access (PICC or CVC). 5
• Short‑term inpatient PN: Both PICCs and non‑tunneled CVCs are suitable. 4
• Medium‑term or home PN: PICCs are appropriate but may limit self‑care by occupying one arm. 6, 4
• Home PN > 3 months: Tunneled catheters are preferable to PICCs. 3, 4

3.4 Chemotherapy

• Vesicant chemotherapy: Requires central venous access via PICC; midlines are inappropriate. 1
• Long‑term oncology patients: Implanted ports have the lowest catheter‑related bloodstream infection (CRBSI) rates and are appropriate only when therapy is expected ≥ 31 days. 6, 1

4. Technical Specifications

• Midline catheters: Length 8–25 cm, terminating below the axillary line; placed in brachial, basilic, or cephalic veins; no routine chest X‑ray required; can remain up to 6 weeks (optimal ≤ 14 days).
• PICC catheters: Length 50–60 cm with tip at the cavo‑atrial junction; placed via basilic or brachial vein using ultrasound guidance and micro‑introducer technique; post‑insertion chest X‑ray mandatory if tip position not confirmed intra‑procedurally; suitable for therapy up to 3 months. 4, 5

5. Complication Prevention

• Infection control: Strict aseptic technique during placement and maintenance for both devices. 2
• Thrombosis prevention: Use the smallest catheter gauge compatible with therapy (catheter diameter ≤ 1⁄3 of vein diameter). 2
• Occlusion prevention: Adhere to proper flushing protocols for both midlines and PICCs. 3

6. Contraindications and Pitfalls

• Do not use midlines for solutions with osmolarity > 850 mOsm/L or pH outside 5–9. 5
• Avoid femoral vein access for PN due to high contamination and thrombosis risk. 5, 4
• Do not place PICCs in patients with stage 3‑5 chronic kidney disease who may need future hemodialysis access. 6
• Avoid high internal jugular approaches (anterior/posterior to sternocleidomastoid) because of difficult exit‑site care and infection risk. 3, 4
• Do not use short peripheral cannulas for home PN due to high dislocation risk. 3, 2
• Avoid subclavian vein access in advanced CKD to preserve future dialysis access options. 6

Guidelines for Midline Catheter Use

1. Indications Based on Expected Duration of Therapy

• For intravenous therapy expected to last ≤ 5 days, conventional peripheral catheters (including ultrasound‑guided placement) are the appropriate choice. 7
• For therapy expected to last 6–14 days, midline catheters are the first‑line device for infusions that are compatible with peripheral administration. 8

2. Specific Clinical Situations

2.1 Difficult Venous Access

• When peripheral veins are difficult to cannulate and the anticipated therapy duration is 6–14 days, a midline catheter or an ultrasound‑guided peripheral catheter should be preferred over a peripherally inserted central catheter (PICC). 7

2.2 Frequent Phlebotomy (≥ 3 draws per day)

• If frequent phlebotomy is required for ≤ 5 days, the evidence is uncertain and the decision should be individualized after weighing risks and benefits. 7

2.3 Residents of Long‑Term Care Facilities

• For patients residing in long‑term care facilities who need 6–14 days of intravenous therapy, a midline catheter is appropriate. 8
• For the same population requiring ≤ 5 days of therapy, conventional peripheral catheters are more appropriate. 8

3. Absolute Contraindications

• Vesicant, irritant, or chemotherapeutic agents mandate central venous access (e.g., PICC) regardless of therapy duration. 7

4. Patient Populations Requiring Special Consideration

4.1 Advanced Chronic Kidney Disease

• Midline catheters should be avoided in patients with chronic kidney disease stage 3b or higher (estimated glomerular filtration rate < 45 mL/min) to preserve peripheral and central veins for future dialysis access. 7
• Nephrology consultation is recommended when the severity of renal impairment is uncertain. 7

4.2 Bilateral Mastectomy or Altered Thoracic Anatomy

• In patients with bilateral mastectomy or significant thoracic anatomical changes, placement of a midline catheter by interventional radiology should be considered if the contralateral arm is not viable. 8

5. Common Errors to Avoid

• Do not use midline catheters for vesicant, irritant, or chemotherapeutic infusions because they lack central venous positioning and carry a high risk of extravasation. 7
• Do not place midline catheters in patients with advanced chronic kidney disease (stage 3–5) who may require future dialysis access. 7

All statements are derived from peer‑reviewed evidence published in 2015 (Annals of Internal Medicine) and reflect current best practices for midline catheter selection and management.